home / stock / rammf / rammf news

RAMMF News and Press, RAMM Pharma From 02/22/22

Stock Information
Company Name: RAMM Pharma
Stock Symbol: RAMMF
Market: OTC
Website: rammpharma.com
Menu
RAMMF RAMMF Quote RAMMF Short RAMMF News RAMMF Articles RAMMF Message Board
Get RAMMF Alerts

News, Short Squeeze, Breakout and More Instantly...
RAMMF - RAMM Provides Update on European Operations

TORONTO, Feb. 22, 2022 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) , a leader in plant-derived cannabinoid pharmaceutical products, is pleased to provide an update on their European operations ...
RAMMF - New CBD Regulatory Framework Published by France's Ministry of Health Opens New Commercial Opportunities for RAMM Pharma's European Operations

TORONTO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- RAMM Pharma Corp., including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) , a leader in plant-derived cannabinoid pharmaceutical products, applauds France’s new regulatory framework for the sal...

RAMMF - RAMM Pharma Corp. Welcomes Proposed Legalization of Recreational Cannabis in Germany

TORONTO, Dec. 01, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) , a leader in plant-derived cannabinoid pharmaceutical products, welcomes the announcement by Germany’s recently formed...

RAMMF - RAMM Pharma Announces Resignation of Director

TORONTO, Sept. 15, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or “ RAMM ”) (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical and other cannabis-based products, announces that Mr. Se...
RAMMF - RAMM Pharma Corp. Announces Intention to Commence Normal Course Issuer Bid

TORONTO, July 06, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) , announces its intention to commence a normal course issuer bid (the “ NCIB ”), under which it may purchase...

RAMMF - RAMM Pharma Completes Acquisition of Canapar Corp.

TORONTO, June 15, 2021 (GLOBE NEWSWIRE) -- Further to its news releases dated May 12 and June 14, 2021, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM ") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical and other ...

RAMMF - Canapar Corp. Receives Shareholder Approval for Business Combination With RAMM Pharma

TORONTO, June 14, 2021 (GLOBE NEWSWIRE) -- Further to its news release dated May 12, 2021, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM ") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical and other cannabis-base...
RAMMF - RAMM Pharma to acquire 100% of European cannabis company Canapar

RAMM Pharma ([[RAMMF]]) has entered into a definitive agreement to purchase 100% of European cannabis company Canapar for a total purchase price of about $26.2M.The deal is to purchase all shares of Canapar that RAMM does not currently own in exchange for about 21.9M RAMM shares at a deemed v...

RAMMF - RAMM Pharma to Acquire 100% of Leading Vertically Integrated European Cannabis Company Canapar Corp.

TORONTO, May 12, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM ") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical and other cannabis-based products, is pleased to announce that the Compa...

RAMMF - RAMM Pharma Receives Federal Pharmaceutical Approval and Registration of NettaVet(TM) 10% CBD Formulation, a First for Veterinary Medicine

TORONTO, April 20, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM") (CSE: RAMM) (OTC: RAMMF) , a leader in plant-derived cannabinoid pharmaceutical products, is pleased to announce that the Uruguayan Minis...
Previous 10 Next 10